Drug-induced hypokalaemia

Current Drug Safety

Volumn 4, Issue 1, 2009, Pages 55-61

  Salem, Chaker B ^a   Hmouda, Houssem ^b   Bouraoui, Kamel ^a  

^a UNIVERSITY OF SOUSSE   (Tunisia)

^b SAHLOUL UNIVERSITY HOSPITAL   (Tunisia)

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BICARBONATE; CALCIUM CHANNEL BLOCKING AGENT; CATECHOLAMINE DERIVATIVE; CHLOROQUINE; CORTICOSTEROID; DECONGESTIVE AGENT; DIACETYLRHEIN; DIURETIC AGENT; DOCUSATE SODIUM; GLUCOSE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; IMMUNOSUPPRESSIVE AGENT; INSULIN; LAXATIVE; PAPAVERINE; PARACETAMOL; PHENOLPHTHALEIN; POTASSIUM; RITODRINE; SALBUTAMOL; TENOFOVIR; TERBUTALINE; THEOPHYLLINE; UNINDEXED DRUG; XANTHINE DERIVATIVE; DRUG;

CARDIOVASCULAR RISK; DIARRHEA; DRUG MEGADOSE; DRUG OVERDOSE; ELECTROLYTE DISTURBANCE; HEART RHYTHM; HUMAN; HYPERKALEMIA; HYPOKALEMIA; INCIDENCE; KALIURESIS; LEUKOCYTOSIS; METABOLIC ACIDOSIS; MORBIDITY; MORTALITY; NEPHROTOXICITY; PATHOPHYSIOLOGY; PATIENT MONITORING; POTASSIUM BLOOD LEVEL; POTASSIUM TRANSPORT; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; VOMITING; AGE; AGED; CARDIOVASCULAR DISEASE; CHEMICALLY INDUCED DISORDER; INTOXICATION; KIDNEY DISEASE; LIVER DISEASE; RISK FACTOR;

AGE FACTORS; AGED; CARDIOVASCULAR DISEASES; HUMANS; HYPOKALEMIA; KIDNEY DISEASES; LIVER DISEASES; OVERDOSE; PHARMACEUTICAL PREPARATIONS; RISK FACTORS;

EID: 63249136733     PISSN: 15748863     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488609787354369     Document Type: Review

References (109)

1. Macdonald JE, Struthers AD. What is the optimal serum potassium level in cardiovascular patients? J Am Coll Cardiol 2004; 43: 155-61.
2. Ahmed A, Zannad F, Love TE, et al. A propensity-matched study of the association of low serum potassium levels and mortality in chronic heart failure. Eur Heart J 2007; 28: 1334-43.
3. Isaac G, Holland OB. Drug-induced hypokalaemia. A cause for concern. Drugs Aging 1992; 2: 35-41.
4. Weiner ID, Wingo CS. Hypokalaemia--consequences, causes, and correction. J Am Soc Nephrol 1997; 8(7): 1179-88.
5. Gennari FJ. Hypokalaemia. N Engl J Med 1998; 339: 451-8.
6. Paice BJ, Paterson KR, Onyanga-Omara F, Donnelly T, Gray JM, Lawson DH. Record linkage study of hypokalaemia in hospitalised patients. Postgrad Med J 1986; 62: 187-91.
7. Riggs JE. Neurologic manifestations of electrolyte disturbances. Neurol Clin 2002; 20: 227-39.
8. Sørensen IJ, Matzen LE. Serum electrolytes and drug therapy of patients admitted to a geriatric department. Ugeskr Laeger 1993; 155: 3921-4.
9. Janko O, Seier J, Zazgornik J. Hypokalaemia--incidence and severity in a general hospital. Wien Med Wochenschr 1992; 142: 78-81.
10. Halevy J, Gunsherowitz M, Rosenfeld JB. Life-threatening hypokalaemia in hospitalized patients. Miner Electrolyte Metab 1988; 14: 163-6.
11. Passare G, Viitanen M, Törring O, Winblad B, Fastbom J. Sodium and potassium disturbances in the elderly: prevalence and association with drug use. Clin Drug Investig 2004; 24: 535-44.
12. Clausen T, Flatman JA. The effect of catecholamines on Na-K transport and membrane potential in rat soleus muscle. J Physiol 1977; 270: 383-414.
13. Udezue E, D'Souza L, Mahajan M. Hypokalaemia after normal doses of nebulized albuterol (salbutamol). Am J Emerg Med 1995; 13: 168-71.
14. Scheinin M, Koulu M, Laurikainen E, Allonen H. Hypokalaemia and other non-bronchial effects of inhaled fenoterol and salbutamol: a placebo-controlled dose-response study in healthy volunteers. Br J Clin Pharmacol 1987; 24: 645-53.
15. Lewis LD, Essex E, Volans GN, Cochrane GM. A study of self poisoning with oral salbutamol--laboratory and clinical features. Hum Exp Toxicol 1993; 12: 397-401.
16. Whyte KF, Reid C, Addis GJ, Whitesmith R, Reid JL. Salbutamol induced hypokalaemia: the effect of theophylline alone and in combination with adrenaline. Br J Clin Pharmacol 1988; 25: 571-8.
17. Braden GL, von Oeyen PT, Germain MJ, Watson DJ, Haag BL. Ritodrine- and terbutaline-induced hypokalaemia in preterm labor: mechanisms and consequences. Kidney Int 1997; 51: 1867-75.
18. Gutman Y, Boonyaviroj P. Inhibition of catecholamine release by alpha-adrenergic activation: interaction with Na, K-ATPase. J Neural Transm 1977; 40: 245-52.
19. Wong KM, Chak WL, Cheung CY, et al. Hypokalaemic metabolic acidosis attributed to cough mixture abuse. Am J Kidney Dis 2001; 38: 390-4.
20. Brown MJ. Hypokalaemia from β2-receptor stimulation by circulating epinephrine. Am J Cardiol 1985; 56: 3D-9D.
21. Seck M, Bruder N, Courtinat C, Pellissier D, François G. Transfer hypokalaemia induced by norepinephrine infusion. Ann Fr Anesth Reanim 1996; 15: 204-6.
22. Darbar D, Smith M, Morike K, Roden D. Epinephrine-induced changes in serum potassium and cardiac repolarization and effects of pretreatment with propranolol and diltiazem. Am J Cardiol 1996; 77: 1351-5.
23. Fang W, Chen J-Y, Fang Y, Huang J-L. Epinephrine overdose-associated hypokalaemia and rhabdomyolysis in a newborn. Pharmacotherapy 2005; 25: 1266-70.
24. Thangathurai D, Mikhail M, Shoemaker W. Implication of epinephrine-induced hypokalaemia during cardiac arrest. Resuscitation 2003; 58: 231.
25. Koh YI, Choi IS. Lactic acidosis associated with the usual theophylline dose in a patient with asthma. Korean J Intern Med 2002; 17: 147-9.
26. Flack JM, Ryder KW, Strickland D, Whang R. Metabolic correlates of theophylline therapy: a concentration-related phenomenon. Ann Pharmacother 1994; 28: 175-9.
27. Appel CC, Myles TD. Caffeine-induced hypokalaemic paralysis in pregnancy. Obstet Gynecol 2001; 97: 805-7.
28. Freed MI, Rastegar A, Bia MJ. Effects of calcium channel blockers on potassium homeostasis. Yale J Biol Med 1991; 64: 177-86.
29. Sugarman A, Kahn T. Calcium channel blockers enhance extrarenal potassium disposal in the rat. Am J Physiol 1986; 250: F695-701.
30. Mimran A, Ribstein J, Sissmann J. Effects of calcium antagonists on adrenaline-induced hypokalaemia. Drugs 1993; 46 (Suppl 2): 103-7.
31. Tishler M, Armon S. Nifedipine-induced hypokalaemia. Drug Intell Clin Pharm 1986; 20: 370-1.
32. Oe H, Taniura T, Ohgitani N. A case of severe verapamil overdose. Jpn Circ J 1998; 62: 72-6.
33. Burghen GA, Etteldorf JN, Fisher JN, Kitabchi AQ. Comparison of high-dose and low-dose insulin by continuous intravenous infusion in the treatment of diabetic ketoacidosis in children. Diabetes Care 1980; 3: 15-20.
34. Binder G, Bosk A, Gass M, Ranke MB, Heidemann PH. Insulin tolerance test causes hypokalaemia and can provoke cardiac arrhythmias. Horm Res 2004; 62: 84-7.
35. Muto S, Sebata K, Watanabe H, et al. Effect of oral glucose administration on serum potassium concentration in hemodialysis patients. Am J Kidney Dis 2005; 46: 697-705.
36. Clemessy JL, Favier C, Borron SW, Hantson PE, Vicaut E, Baud FJ. Hypokalaemia related to acute chloroquine ingestion. Lancet 1995; 346: 877-80.
37. Marquardt K, Albertson TE. Treatment of hydroxychloroquine overdose. Am J Emerg Med 2001; 19: 420-4.
38. Ok SH, Chung YW, Sohn JT, Jung JM, Chung YK. Severe hypokalaemia occurring during barbiturate coma therapy in a patient with severe acute head injury. Acta Anaesthesiol Scand 2005; 49: 883-4.
39. Hall RJ, Cameron IR. The effect of pentobarbitone on plasma and intracellular sodium, potassium and pH in rabbit cardiac and skeletal muscle. Clin Sci (Lond) 1979; 57: 549-51.
40. van Heerden PV, Chew G. Severe hypokalaemia due to lignocaine toxicity. Anaesth Intensive Care 1996; 24: 128-9.
41. Kallmeyer JC, Macleod IN, Bhagwan B. Marked hypokalaemic rhabdomyolysis due to purgative abuse. South Afr Med J 1994; 84: 50.
42. Chin RL. Laxative-induced hypokalaemia. Ann Emerg Med 1998; 32: 517-8.
43. Hill AG, Parry BR. Hypokalaemia following bowel cleansing with sodium phosphate. N Z Med J 1996; 109: 347.
44. Craig JC, Hodson EM, Martin HC. Phosphate enema poisoning in children. Med J Aust 1994; 160: 347-51.
45. Andrejak M, Lafon B, Decocq G, et al. Antibiotic-associated pseudomembranous colitis: retrospective study of 48 cases diagnosed by colonoscopy. Therapie 1996; 51: 81-6.
46. Katerinis I, Fumeaux Z. Hypokalaemia: diagnosis and treatment. Rev Med Suisse 2007; 3: 579-82.
47. Saif MW, Fekrazad MH, Ledbetter L, Diasio RB. Hypokalaemia secondary to capecitabine: a hidden toxicity? Ther Clin Risk Manage 2007; 3: 177-80.
48. Thomas-Anterion C, Guy C, Vial F, et al. Unexplained chronic diarrhea, apropos of 4 new cases under Cyclo 3 fort and review of the literature. Rev Med Intern 1993; 14: 215-7.
49. Simons P, Nadra I, McNally PG. Metabolic alkalosis and myoclonus. Postgrad Med J 2003; 79: 414-5.
50. Gunawan CA, Harijanto PN, Nugroho A. Quinine-induced Arrhytmia in a Patient with Severe Malaria. Acta Med Indones 2007; 39: 27-32.
51. Morgan DB, Davidson C. Hypokalaemia and diuretics: an analysis of publications. Br Med J 1980; 280: 905-8.
52. Passarelli MC, Jacob-Filho W, Figueras A. Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause. Drugs Aging 2005; 22: 767-77.
53. Hamdy RC, Tovey J, Perera N. Hypokalaemia and diuretics. BMJ 1980; 280: 1187.
54. Clayton JA, Rodgers S, Blakey J, Avery A, Hall IP. Thiazide diuretic prescription and electrolyte abnormalities in primary care. Br J Clin Pharmacol 2006; 61: 87-95.
55. Rose BD. Diuretics. Kidney Int 1991; 39: 336-52.
56. Alfonzo AV, Isles C, Geddes C, Deighan C. Potassium disorders--clinical spectrum and emergency management. Resuscitation 2006; 70: 10-25.
57. Alderman MH. New onset diabetes during antihypertensive therapy. Am J Hypertens 2008; 21: 493-9.
58. Grobbee DE, Hoes AW. Non-potassium-sparing diuretics and risk of sudden cardiac death. J Hypertens 1995; 13: 1539-45.
59. Hoes AW, Grobbee DE, Lubsen J. Sudden cardiac death in patients with hypertension. An association with diuretics and beta-blockers? Drug Saf 1997; 16: 233-41.
60. Cohen JD, Neaton JD, Prineas RJ, Daniels KA. Diuretics, serum potassium and ventricular arrhythmias in the Multiple Risk Factor Intervention Trial. Am J Cardiol 1987; 60: 548-54.
61. The Hypertension Detection and Follow-up Program Cooperative Research Group. The effect of antihypertensive drug treatment on mortality in the presence of resting electrocardiographic abnormalities at baseline: the HDFP experience. Circulation 1984; 70: 996-1003.
62. Papademetriou V. Diuretics, hypokalaemia and cardiac arrhythmia: a 20-year controversy. J Clin Hypertens (Greenwich) 2006; 8: 86-92.
63. Critchlow AS, Freeborn SN, Roddie RA. Potassium supplements during treatment of glaucoma with acetazolamide. BMJ (Clin Res Ed) 1984; 289: 21.
64. Lipner HI, Ruzany F, Dasgupta M, Lief PD, Bank N. The behavior of carbenicillin as a nonreabsorbable anion. J Lab Clin Med 1975; 86: 183-94.
65. Nanji AA, Lindsay J. Ticarcillin associated hypokalaemia. Clin Biochem 1982; 15: 118-9.
66. Brunner FP, Frick PG. Hypokalaemia, metabolic alkalosis and hypernatraemia due to massive sodium penicillin therapy. BMJ 1986; 4: 550-2.
67. Margolin L. Impaired rehabilitation secondary to muscle weakness induced by meropenem. Clin Drug Investig 2004; 24: 61-2.
68. Brass EP, Thompson WL. Drug-induced electrolyte abnormalities. Drugs 1982; 24: 207-28.
69. Steiner RW, Omachi AS. A Bartter's-like syndrome from capreomycin, and a similar gentamicin tubulopathy. Am J Kidney Dis 1986; 7: 245-9.
70. Shiah CJ, Tsai DM, Liao ST, Siauw CP, Lee LS. Acute muscular paralysis in an adult with subclinical Bartter's syndrome associated with gentamicin administration. Am J Kidney Dis 1994; 24: 932-5.
71. Shin S, Furin J, Alcántara F, et al. Hypokalaemia among patients receiving treatment for multidrug-resistant tuberculosis. Chest 2004; 125: 974-80.
72. Chou CL, Chen YH, Chau T, Lin SH. Acquired bartter-like syndrome associated with gentamicin administration. Am J Med Sci 2005; 329: 144-9.
73. Barton CH, Pahl M, Vaziri ND, Cesario T. Renal magnesium wasting associated with amphotericin B therapy. Am J Med 1984; 77: 471-4.
74. Subirà M, Martino R, Gómez L, Martí JM, Estany C, Sierra J. Low-dose amphotericin B lipid complex vs conventional amphotericin B for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies--a randomized, controlled trial. Eur J Haematol 2004; 72: 342-7.
75. Falagas ME, Ntziora F, Betsi GI, Samonis G. Caspofungin for the treatment of fungal infections: a systematic review of randomized controlled trials. Int J Antimicrob Agents 2007; 29: 136-43.
76. Bearden DT, Muncey LA. The effect of amiloride on amphotericin B-induced hypokalaemia. J Antimicrob Chemother 2001; 48: 109-11.
77. Ural AU, Avcu F, Cetin T, et al. Spironolactone: is it a novel drug for the prevention of amphotericin B-related hypokalaemia in cancer patients? Eur J Clin Pharmacol 2002; 57: 7713.
78. Ruiz-Contreras J, Rodriguez R, Gómez de Quero P, González Tomé MI, Sánchez Díaz JI. Severe hypokalaemia and rhabdomyolysis associated with itraconazole therapy. Pediatr Infect Dis J 2003;22:1024-5.
79. Wang A, Zhang Y, He L, et al. Clinical study on the efficacy and safety of intravenous itraconazole infusion for the treatment of invasive fungal infection in china. Jpn J Infect Dis 2006; 59: 370-6.
80. Kidd D, Ranaghan EA, Morris TC. Hypokalaemia in patients with acute myeloid leukaemia after treatment with fluconazole. Lancet 1989; 1: 1017.
81. Li N, Wang GF, Wu YF, et al. Side effects of glucocorticosteroids in the management of 1291 patients of SARS. Beijing Da Xue Xue Bao 2004; 36: 519-24.
82. Tsai WS, Wu CP, Hsu YJ, Lin SH. Life-threatening hypokalaemia in an asthmatic patient treated with high-dose hydrocortisone. Am J Med Sci 2004; 327: 152-5.
83. Ramsahoye BH, Davies SV, el-Gaylani N, Sandeman D, Scanlon MF. The mineralocorticoid effects of high dose hydrocortisone. BMJ 1995; 310: 656-7.
84. Thorn GW. Clinical considerations in the use of corticosteroids. N Engl J Med 1966; 274: 775-81.
85. Hussain RM, McIntosh SJ, Lawson J, Kenny RA. Fludrocortisone in the treatment of hypotensive disorders in the elderly. Heart 1996; 76: 507-9.
86. Qian SZ. Gossypol-hypokalaemia interrelationships. Int J Androl 1985; 8: 313-24.
87. Metcalfe MJ, Entrican JH. Carbenoxolone and hypokalaemia. Lancet 1987; 2: 1525-6.
88. Hoffman AR, Feldman D. Successful long-term treatment of refractory Cushing's disease with high-dose mifepristone (RU 486). J Clin Endocrinol Metab 2001; 86: 3568-73.
89. Mohammadianpanah M, Omidvari S, Mosalaei A, Ahmadloo N. Cisplatin-induced hypokalaemic paralysis. Clin Ther 2004; 26: 1320-3.
90. Shepp DH, Curtis S, Rooney JF. Causes and consequences of hypokalaemia in patients on tenofovir disoproxil fumarate. AIDS 2007; 21: 1479-81.
91. Cirino CM, Kan VL. Hypokalaemia in HIV patients on tenofovir. AIDS 2006; 20: 1671-3.
92. Gearhart MO, Sorg TB. Foscarnet-induced severe hypomagnesemia and other electrolyte disorders. Ann Pharmacother 1993; 27: 285-9.
93. Thuss-Patience PC, Peters U, Jurkat-Rott K, et al. Acute hypokalaemic tetraparesis induced by intravenous methotrexate. J Clin Oncol 2003; 21: 1896-7.
94. Morales JM, Andrés A, Dominguez-Gil B, et al. Tubular function in patients with hypokalaemia induced by sirolimus after renal transplantation. Transplant Proc 2003; 35: 154S-156S.
95. Lin CJ, Chen YC, Chen HH, Liu CC, Wu CJ. Life-threatening ventricular arrhythmia induced by hypokalaemia during sodium bicarbonate infusion. South Afr Med J 2008; 101: 215-6.
96. Carvalhana V, Burry L, Lapinsky SE. Management of severe hyperkalemia without hemodialysis: case report and literature review. J Crit Care 2006; 21: 316-21.
97. Vaziri ND, Stokes J, Treadwell TR. Lactic acidosis, a complication of papaverine overdose. Clin Toxicol 1981; 18: 417-23.
98. Pakravan N, Bateman DN, Goddard J. Effect of acute paracetamol overdose on changes in serum and urine electrolytes. Br J Clin Pharmacol 2007; 64: 824-32.
99. Waring WS, Stephen AF, Malkowska AM, Robinson OD. Acute acetaminophen overdose is associated with dose-dependent hypokalaemia: a prospective study of 331 patients. Basic Clin Pharmacol Toxicol 2008; 102: 325-8.
100. Anderson DC, Cooper AF, Naylor GJ. Vitamin D intoxication, with hypernatraemia, potassium and water depletion, and mental depression. Br Med J 1968; 4:744-6.
101. Chen YC, Fang JT, Chang CT, Chou HH. Thyrotoxic periodic paralysis in a patient abusing thyroxine for weight reduction. Ren Fail 2001; 23: 139-42.
102. Clausen T. Clinical and therapeutic significance of the Na+,K+ pump*. Clin Sci (Lond) 1998; 95: 3-17.
103. Malik AR, Wolf PK, Ravasia S. Hypokalaemia from risperidone and quetiapine overdose. Can J Psychiatry 2005; 50: 76.
104. Karamanolis G, Tzathas C, Triantafyllou K, Tsiamoulos Z, Ladas S. Symptomatic hypokalaemia associated with infliximab in a patient with Crohn's disease. Inflamm Bowel Dis 2006; 12:1010-1.
105. Gaul C, Heckmann JG, Druschky A, Schöcklmann H, Neundörfer B, Erbguth F. Renal tubular acidosis with severe hypokalaemic tetraparesis after ibuprofen intake. Dtsch Med Wochenschr 1999; 124: 483-6.
106. Turner SR, Pinsk M. Ondansetron-associated Hypokalaemia in a 2-year-old With Pre-B-cell ALL. J Pediatr Hematol Oncol 2008; 30: 58-60.
107. Bouvresse S, Matichard E, Mahé E, et al. Symptomatic hypokalaemia caused by meglumine antimoniate. Ann Dermatol Venereol 2007; 134: 387-8.
108. Lawson DH, Murray RM, Parker JL, Hay G. Hypokalaemia in megaloblastic anaemias. Lancet 1970; 2: 588-90.
109. Viens P, Thyss A, Garnier G, Ayela P, Lagrange M, Schneider M. GM-CSF treatment and hypokalaemia. Ann Intern Med 1989; 111: 263.